Last reviewed · How we verify
NCT05006378
Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
NA trial testing Chamomile Tea in Coagulation Disorder in 12 participants. Completed in 19 January 2022.
19 January 2022
Quick facts
| Lead sponsor | Stony Brook University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 12 |
| Start date | 31 August 2021 |
| Primary completion | 19 January 2022 |
| Estimated completion | 19 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Chamomile Tea — full drug profile →
- Chamomile Extract Capsule
- Placebo Capsule
Conditions studied
- Coagulation Disorder — all drugs for Coagulation Disorder →
Sponsor
Stony Brook University
Who can join
Adults 18 to 75, any sex, with Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized, placebo-controlled complete crossover study will investigate the impact of chamomile ingestion on coagulation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of chamomile intake on blood coagulation tests in healthy volunteers: a randomized, placebo-controlled, crossover trial.
Schwartz JA, Romeiser JL, Kimura R, Senzel L, et al · · 2023 · cited 4× · PMID 37730613 · DOI 10.1186/s13741-023-00339-7
Verify or expand the search:
- PubMed search for NCT05006378
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Chamomile Tea
Trials testing the same drug.
- NCT05272475 — The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers · NA · completed
- NCT03526081 — Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides · NA · completed
Other recruiting trials for Coagulation Disorder
Currently open trials in the same condition.
- NCT06481995 — SWIFT - SWIss Factor XIII Trial in PPH · Phase 4 · recruiting
- NCT05139589 — The ENDOCARDITIS AUMC Data Collection · recruiting
- NCT05156983 — A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery · Phase 3 · recruiting
- NCT05645081 — Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke · recruiting
- NCT04524637 — The Utility of Thromboelastography in Traumatic Brain Injury · recruiting
Other Stony Brook University trials
Trials by the same sponsor.
- NCT07478250 — First Responder Safety Training (FiRST) · NA · not yet recruiting
- NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting
- NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
- NCT07114900 — Randomized Controlled Physical Activity App Intervention for Black Women · Phase 3 · active not recruiting
- NCT05245227 — Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006378 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stony Brook University
- Last refreshed: 10 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006378.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing